• 1
    Niederkorn JY. The immune privilege of corneal grafts. J Leukoc Biol 2003; 74: 167171.
  • 2
    Aiken-O'Neill P, Mannis MJ. Summary of comeal transplant activity Eye Bank Association of America. Cornea 2002; 21: 13.
  • 3
    Sano Y, Ksander BR, Streilein JW. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens. Invest Ophthalmol Vis Sci 1997; 38: 11301138.
  • 4
    Volker-Dieben HJ, Kok-van Alphen CC, Lansbergen Q et al. Different influences on corneal graft survival in 539 transplants. Acta Ophthalmol (Copenh) 1982; 60: 190202.
  • 5
    Chen L, Hamrah P, Cursiefen C et al. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med 2004; 10: 813815.
  • 6
    Abraham NG, Da Silva JL, Lavrovsky Y et al. Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest Ophthalmol Vis Sci 1995; 36: 22022210.
  • 7
    Hegde S, Niederkorn JY. The role of cytotoxic T lymphocytes in corneal allograft rejection. Invest Ophthalmol Vis Sci 2000; 41: 33413347.
  • 8
    Sonoda Y, Streilein JW. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J Immunol 1993; 150: 17271734.
  • 9
    Yamada J, Ksander BR, Streilein JW. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 2001; 42: 386392.
  • 10
    Yamada J, Kurimoto I, Streilein JW. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice. Invest Ophthalmol Vis Sci 1999; 40: 26142621.
  • 11
    Niederkorn JY. The immunology of corneal transplantation. Dev Ophthalmol 1999; 30: 129140.
  • 12
    Maumenee A. The influence of donor-recipient sensitization on corneal grafts. Am J Ophthalmol 1951; 34: 142152.
  • 13
    Hegde S, Beauregard C, Mayhew E et al. CD4(+) T-cell-mediated mechanisms of corneal allograft rejection: role of Fas-induced apoptosis. Transplantation 2005; 79: 2331.
  • 14
    He YG, Ross J, Niederkorn JY. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci 1991; 32: 27232728.
  • 15
    Ayliffe W, Alam Y, Bell EB et al. Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody. Br J Ophthalmol 1992; 76: 602606.
  • 16
    Hargrave SL, Hay C, Mellon J, Mayhew E, Niederkorn JY. Fate of MHC-matched corneal allografts in Th1-deficient hosts. Invest Ophthalmol Vis Sci 2004; 45: 11881193.
  • 17
    He Y, Mellon J, Apte R et al. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival. Invest Ophthalmol Vis Sci 1994; 35: 32183225.
  • 18
    He YG, Mellon J, Niederkorn JY. The effect of oral immunization on corneal allograft survival. Transplantation 1996; 61: 920926.
  • 19
    Ma D, Li XY, Mellon J et al. Immunologic phenotype of hosts orally immunized with corneal alloantigens. Invest Ophthalmol Vis Sci 1998; 39: 744753.
  • 20
    He YG, Niederkorn JY. Depletion of donor-derived Langerhans cells promotes corneal allograft survival. Cornea 1996; 15: 8289.
  • 21
    Skelsey ME, Mayhew E, Niederkorn JY. CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye. Immunology 2003; 110: 1829.
  • 22
    Fujiwara H, Hamaoka T, Shearer GM et al. The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes. J Immunol 1980; 124: 863869.
  • 23
    Ksander BR, Sano Y, Streilein JW. Role of donor-specific cytotoxic T cells in rejection of corneal allografts in normal and high-risk eyes. Transpl Immunol 1996; 4: 4952.
  • 24
    Bourges JL, Valamanesh F, Torriglia A et al. Cornea graft endothelial cells undergo apoptosis by way of an alternate (caspase-independent) pathway. Transplantation 2004; 78: 316323.
  • 25
    Larkin DF, Alexander RA, Cree IA. Infiltrating inflammatory cell phenotypes and apoptosis in rejected human corneal allografts. Eye 1997; 11: 6874.
  • 26
    Stuart PM, Griffith TS, Usui N et al. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 1997; 99: 396402.
  • 27
    Yamagami S, Kawashima H, Tsuru T et al. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 1997; 64: 11071111.
  • 28
    Wilson SE, Li Q, Weng J et al. The Fas-Fas ligand system and other modulators of apoptosis in the cornea. Invest Ophthalmol Vis Sci 1996; 37: 15821592.
  • 29
    Seino K, Kayagaki N, Bashuda H et al. Contribution of Fas ligand to cardiac allograft rejection. Int Immunol 1996; 8: 13471354.
  • 30
    Sonoda KH, Taniguchi M, Stein-Streilein J. Long-term survival of corneal allografts is dependent on intact CD1d- reactive NKT cells. J Immunol 2002; 168: 20282034.